TRST:CA:TSX-CannTrust Holdings Inc.

EQUITY | Drug Manufacturers | Toronto Stock Exchange

Last Closing

CAD 13.31

Change

+0.39 (+3.02)%

Market Cap

CAD 1.41B

Volume

1.47M

Analyst Target

CAD 14.59
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-03-21 )

Largest Industry Peers for Drug Manufacturers

ETFs Containing TRST:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers) Market Performance vs. Exchange (Toronto Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 102.59% 94% A 99% N/A
Dividend Return N/A N/A N/A N/A F
Total Return 102.59% 94% A 99% N/A
Trailing 12 Months  
Capital Gain 59.21% 80% B- 98% N/A
Dividend Return N/A N/A N/A N/A F
Total Return 59.21% 80% B- 98% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain 1.00% 40% F 55% F
Dividend Return 1.00% 40% F 33% F
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) 5.83% 90% A- 77% C+
Risk Adjusted Return 17.24% 50% F 37% F
Market Capitalization 1.41B 65% D 89% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers) Ratio vs. Market (Toronto Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 66.55 12% 5%
Price/Book Ratio 7.52 24% 6%
Price / Cash Flow Ratio -27.73 76% 97%
Price/Free Cash Flow Ratio -28.32 88% 92%
Management Effectiveness  
Return on Equity 13.72% 100% 78%
Return on Invested Capital 15.39% 100% 85%
Return on Assets 12.10% 100% 92%
Debt to Equity Ratio 6.00% 73% 89%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector